1 set, and verified in the validation set and
pooled analysis.
2 t sonidegib, had enough studies to warrant a
pooled analysis.
3 us, and tumor histology, is validated by our
pooled analysis.
4 n total, 2,038 patients were included in the
pooled analysis.
5 Significance level was set at .01 for
pooled analysis.
6 ition that was recently confirmed in a major
pooled analysis.
7 e was no between-trial heterogeneity for any
pooled analysis.
8 BDES and BMES at validation, and 0.87 in the
pooled analysis.
9 n improved specificity from 61 to 78% in the
pooled analysis.
10 to body mass index (BMI) groups, in a large
pooled analysis.
11 A total of 479 patients were included in the
pooled analysis.
12 d with risk of breast cancer subtypes in the
pooled analysis.
13 pulations was tested via chi2 tests before a
pooled analysis.
14 ned after the 2011 PSP GWAS, were used for a
pooled analysis.
15 lacebo in ORBIT-4, but not in ORBIT-3 or the
pooled analysis.
16 from the ASCEND trial) were included in the
pooled analysis.
17 2, and 55.4% versus 46.7% (P = 0.003) in the
pooled analysis.
18 ime, 285 minutes) contributed to the present
pooled analysis (
120 with internal carotid artery occlus
19 tudies; 11,936 cases, 18,714 controls) and a
pooled analysis (
14 studies; 5,068 cases, 7,876 controls
20 In this
pooled analysis,
2,282 patients underwent both IGRA and
21 In the
pooled analysis,
390 (96%) of 406 adults and 133 (95%) o
22 In a
pooled analysis,
4 of the 12 risk variants were strongly
23 In the
pooled analysis,
525 of 659 patients (79.7%) in the dalb
24 In a
pooled analysis,
563 patients received tolevamer, 289 re
25 nferiority at a -10% margin in both studies (
pooled analysis:
655 [91%] of 716 in the two-drug regime
26 In the
pooled analysis,
a similar proportion of participants in
27 The
pooled analysis also revealed that maternal overweight o
28 Pooled analysis also showed significant improvements in
29 he dosing interval, 157 ng/mL (28.6-1360) in
pooled analysis and 315 ng/mL (108-1360) in CYP2B6 516TT
30 athogen associated with intussusception in a
pooled analysis and quantitative subanalyses.
31 d summary risk estimates across cohorts with
pooled analysis and random-effects meta-analysis methods
32 ysis is highly consistent with rectal cancer
pooled analysis and SEER rectal cancer analyses, support
33 s, and significantly lower (P < 0.05) in the
pooled analysis,
as was plasma glutamine.
34 The authors carried out a
pooled analysis based on primary data (1960-2001) from 1
35 In
pooled analysis,
baseline creatinine clearance was assoc
36 ral or bilateral VI in general population of
pooled analysis but were identified as risk factors in s
37 In the
pooled analysis,
consumption of >/=10 mg isoflavones/d w
38 Our
pooled analysis could not validate pathological complete
39 In this
pooled analysis,
CT significantly improved PFS1, PFS2, a
40 This
pooled analysis did not show evidence of a benefit for s
41 In conclusion, this large
pooled analysis did not support an overall association b
42 For this
pooled analysis,
eligible patients were aged 1 month or
43 The current
pooled analysis examines the efficacy and safety of this
44 In the
pooled analysis,
exercise training was associated with s
45 eks, we noted significant differences in the
pooled analysis favouring pirfenidone therapy compared w
46 risk ratio favoring drug over placebo in the
pooled analysis for FM30 version 3 (short version) was 1
47 Favorable associations were found in the
pooled analysis for intakes of vitamins E and B(6) and f
48 In the present large-scale
pooled analysis from 2 multicenter randomized trials, ea
49 This is a
pooled analysis from 2 trials assessing the effects of t
50 In a patient-level
pooled analysis from 4 all-comers trials, 6081 patients
51 e 95 lipid-associated loci were novel to the
pooled analysis from over 100 000 individuals.
52 Based on a
pooled analysis from the 3 phase 3 CHAMPION trials, cang
53 In a patient-level
pooled analysis from the Harmonizing Outcomes With Revas
54 copathological subgroups of interest in this
pooled analysis,
further research is needed to identify
55 a modest increase in overall mortality in a
pooled analysis (
hazard ratio [HR] comparing extreme dec
56 io, 1.17; CI, 1.00-1.36; P=0.045) and in the
pooled analysis (
hazard ratio, 1.12; CI, 1.00-1.24; P=0.
57 In the
pooled analysis,
higher circulating 25(OH)D(3) concentra
58 Classical approaches for meta-analysis or
pooled analysis,
however, might not be suitable for such
59 We did a
pooled analysis in the intention-to-treat population usi
60 m baseline to year 3 were not significant in
pooled analysis in the second eyes or the previously inj
61 The
pooled analysis included 1,699 cases and 2,422 controls
62 Our
pooled analysis included all randomly assigned patients
63 This
pooled analysis included data from 67 phase I to IV clin
64 This
pooled analysis includes 1 of the largest patient-level
65 However, in a prespecified
pooled analysis incorporating results from two previous
66 Results from this
pooled analysis indicate that higher concentrations of c
67 The results of
pooled analysis indicated that none of the six investiga
68 Pooled analysis indicated that only G12A was associated
69 This
pooled analysis involving a large patient cohort showed
70 Pooled analysis involving children 1 week to 59 months o
71 distinguished all three mutagens and in the
pooled analysis IR was associated with mutational signat
72 In this large
pooled analysis,
late age at last birth was independentl
73 In a
pooled analysis,
low-frequency HIV-1 drug resistance mut
74 In the
pooled analysis,
maternal smoking only during pregnancy
75 In the
pooled analysis,
median time from discontinuation as a r
76 Consistent with the
pooled analysis,
meta-analyses for all-cause mortality a
77 In the
pooled analysis (
n = 11,635), the RR of death was reduce
78 ed disorders (ICD F20-29) were included in a
pooled analysis (
N = 1396).
79 In a
pooled analysis (
n = 59), we observed a significant diff
80 global policy, a detailed meta-analysis and
pooled analysis needs to be undertaken using data from b
81 In this
pooled analysis no association was observed between omal
82 s in both subpopulations separately and in a
pooled analysis (
odds ratio 0.54, 95% CI 0.39-0.75, p<0.
83 ctive studies, 35 case-control studies and 1
pooled analysis of 10 cohort and 14 case-control studies
84 In a retrospective
pooled analysis of 11 clinical trials of lenalidomide-ba
85 This study represents a patient-level
pooled analysis of 12 459 patients recruited in 6 random
86 e in relation to pancreatic cancer risk in a
pooled analysis of 14 prospective studies from North Ame
87 Here, we present an updated
pooled analysis of 148 patients treated with daratumumab
88 We investigated these associations in a
pooled analysis of 18 cohort studies.
89 Pooled analysis of 2 multicenter, randomized clinical tr
90 This was a
pooled analysis of 2 prospective studies including 61,64
91 treatment imposed by CD49d was estimated by
pooled analysis of 2,972 CLLs; Cox analysis stratified b
92 In a
pooled analysis of 20 prospective studies from the Unite
93 rrence and death across all time points in a
pooled analysis of 20,898 patients with colon cancer fro
94 DESIGN, SETTING, AND PARTICIPANTS: A
pooled analysis of 26 observational studies on the survi
95 nts that occur at SBP/DBP <140/90 mm Hg in a
pooled analysis of 3 contemporary US cohorts: the REGARD
96 Patient-level
pooled analysis of 3 randomized clinical trials was unde
97 Pooled analysis of 3 studies found higher odds of AD in
98 For generalized anxiety disorder, a
pooled analysis of 3 trials showed that quetiapine was a
99 total of 164 studies were included, allowing
pooled analysis of 31 potential prognostic factors.
100 A
pooled analysis of 37,568 patients in 25 randomized tria
101 umab (AMG 145) on lipoprotein (Lp)(a) from a
pooled analysis of 4 phase II trials.
102 In a
pooled analysis of 4 randomized trials, 1,748 patients w
103 We performed a patient-level
pooled analysis of 4 randomized, placebo-controlled tria
104 Pooled analysis of 4 studies found higher odds of AD in
105 Pooled analysis of 4 trials resulted in a statistically
106 In a
pooled analysis of 4 US epidemiologic studies (1993-2001
107 We conducted an individual-based
pooled analysis of 45 twin cohorts from 20 countries, in
108 A
pooled analysis of 5 international (Australia, New Zeala
109 DESIGN, SETTING, AND PARTICIPANTS:
Pooled analysis of 5 longitudinal cohort studies: Athero
110 This was a
pooled analysis of 515 eyes from 360 patients 18 to 49 y
111 In a
pooled analysis of 563 255 participants in 22 cohorts, b
112 In a
pooled analysis of 6 birth cohorts (Ntotal = 15,299), we
113 We performed a
pooled analysis of 6 population-based studies within the
114 Recently, a
pooled analysis of 6 randomized trials comparing the rad
115 In a collaborative
pooled analysis of 7 endovascular databases, we assessed
116 We conducted a
pooled analysis of 7 nested case-control studies in the
117 In a
pooled analysis of 8,692 NHL cases and 9,260 controls fr
118 We conducted a
pooled analysis of 869 individual newly diagnosed elderl
119 DESIGN, SETTING, AND PARTICIPANTS:
Pooled analysis of 9 cohort studies (collected between 1
120 A
pooled analysis of 9 studies reporting mortality reveale
121 dies of six distinct cancers and another for
pooled analysis of a case-control study of glioma, a cla
122 METHODS AND This is a
pooled analysis of ACRIN-PA (American College of Radiolo
123 In a
pooled analysis of all 19 studies, children with eczema
124 In the second part, we performed a
pooled analysis of all studies published between 1976 an
125 In the
pooled analysis of ASCOT, ELSA, and NPHSII, there was no
126 15% lower risk of T2D, respectively, in the
pooled analysis of both cohorts.
127 n=238; p=0.049, 1.22 [1.00-1.48]) and in the
pooled analysis of both stages (n=1239; p=1.3 x 10(-10),
128 A
pooled analysis of both studies yielded an estimate of t
129 , and New Zealand between 1985 and 2010 (the
Pooled Analysis of Case-Control Studies on the Joint Eff
130 The authors present a meta- and a
pooled analysis of case-control studies that examined th
131 A recent
pooled analysis of clinical trials showed that nuts are
132 ons are informed by the findings of a recent
pooled analysis of clinical trials that compared 6 month
133 present large-scale, individual patient data
pooled analysis of contemporary PCI trials, women had a
134 infections in endemic populations based on a
pooled analysis of cross-sectional data.
135 We did a
pooled analysis of cross-sectional survey data that were
136 A
pooled analysis of data from 1,359 patients in 4 phase I
137 In a
pooled analysis of data from 12 international cohorts of
138 We performed a
pooled analysis of data from 1594 patients with CD who p
139 gregation of glioma, the authors performed a
pooled analysis of data from 2 large glioma case-control
140 In a
pooled analysis of data from 5 statin trials, intensive-
141 In a
pooled analysis of data from 7 observational studies of
142 In a
pooled analysis of data from both ORBIT-3 and ORBIT-4, t
143 , we report here an individual patient-level
pooled analysis of data from five trials comparing anthr
144 Based on a
pooled analysis of data from individual patients with PL
145 In a
pooled analysis of data from South and East Asian countr
146 We did a
pooled analysis of data from three trials that assessed
147 We therefore did a
pooled analysis of data to investigate the association b
148 Pooled analysis of EDIPS trial data reinforces evidence
149 Pooled analysis of eight clinical trials (N = 985) from
150 The re-infection rate (95% CI) in
pooled analysis of eight one-stage studies (147 particip
151 Prior
pooled analysis of eribulin studies (301 and 305) indica
152 n of the largest European trial, NELSON, and
pooled analysis of European CT screening trials, we disc
153 r GOLD 2007 and 2011, we did a patient-based
pooled analysis of existing data.
154 We conducted a
pooled analysis of four birth cohorts (children's center
155 We conducted a
pooled analysis of HL risk focusing on type and timing o
156 Finally, a
pooled analysis of in-house and published datasets was c
157 In this
pooled analysis of individual data from 9 selected cohor
158 The authors performed the first
pooled analysis of individual participant data from comp
159 We performed a
pooled analysis of individual participant data using all
160 th dose-response meta-analysis and, finally,
pooled analysis of individual participant data, add insi
161 We did a
pooled analysis of individual patient data derived from
162 We did a systematic review and
pooled analysis of individual patient data from 8382 par
163 We did a
pooled analysis of individual patient data from cohort s
164 th metastatic breast cancer by undertaking a
pooled analysis of individual patient data.
165 We did a preplanned
pooled analysis of individual patient-level data acquire
166 We did a
pooled analysis of individual patient-level data, acquir
167 We did a
pooled analysis of individual-level data from nationally
168 DESIGN, SETTING, AND PARTICIPANTS: A
pooled analysis of individual-participant data from the
169 We performed a
pooled analysis of long-term outcomes in patients with M
170 In the
pooled analysis of MAGI2, two large deletions were found
171 Our
pooled analysis of MC1R genetic data of young patients w
172 In a
pooled analysis of more than 31,000 women of East-Asian,
173 These findings illustrate the utility of
pooled analysis of mouse and human sequencing data.
174 This
pooled analysis of multicenter, prospective RTOG bladder
175 We did a
pooled analysis of new, harmonised, individual-level ana
176 We conducted a
pooled analysis of one-year mortality data on ART accoun
177 In this patient-level
pooled analysis of PARTNER 2 patients who underwent tran
178 his prospectively planned individual-patient
pooled analysis of patient cases from five adjuvant tria
179 velopment of clinical events, we conducted a
pooled analysis of patient-level data from the 10 random
180 This prespecified,
pooled analysis of patient-level data from three trials
181 Similarly,
pooled analysis of pediatric and adult cohorts indicated
182 ifference in specificity was detected in the
pooled analysis of PET and SPECT MPI.
183 s fat intake by country, age, and sex from a
pooled analysis of population health surveys, and region
184 This study used patient-level
pooled analysis of post-cardiac arrest patients with sho
185 ased risk of type 1 diabetes by performing a
pooled analysis of previous studies using individual pat
186 nce of Electrical Storm) is a patient-level,
pooled analysis of previously published data sets.
187 ident, sporadic colorectal adenoma risk in a
pooled analysis of primary data from 3 colonoscopy-based
188 Retrospective
pooled analysis of prospectively collected data.
189 We did a
pooled analysis of published and unpublished individual-
190 We compared outcomes to
pooled analysis of published studies in solid tumors wit
191 In 2007, a
pooled analysis of randomised trials in Europe demonstra
192 Conclusion This large, prospective,
pooled analysis of randomized chemotherapy, immunotherap
193 Pooled analysis of randomized controlled trials of intra
194 In a
pooled analysis of randomized trial data, use of statin
195 In a
pooled analysis of randomized trials in unfavorable-risk
196 Methods We reviewed
pooled analysis of rare end points across cohorts, regar
197 Pooled analysis of raw metagenomes showed that the choli
198 Pooled analysis of RH cells showed high power and resolu
199 Data from a
pooled analysis of risk factors indicate that the higher
200 Pooled analysis of seven studies showed increased odds o
201 In a
pooled analysis of short-term trials, short-term treatme
202 A prospective,
pooled analysis of six randomised phase 3 trials was don
203 In this prospective,
pooled analysis of six randomised phase 3 trials, we inc
204 ment of lung cancer, the authors conducted a
pooled analysis of studies in the International Lung Can
205 was no significant difference in risk in the
pooled analysis of studies that compared rainwater to im
206 he aim of the current study was to conduct a
pooled analysis of studies that have investigated the pr
207 In a
pooled analysis of surveys that measured malaria, stunti
208 Compared with baseline,
pooled analysis of ten participants showed improvements
209 Pooled analysis of the 26 unique studies demonstrated a
210 Pooled analysis of the 3 asthma-ascertained samples show
211 A
pooled analysis of the 5 trials completed by early 2005
212 Pooled analysis of the 6 prospective studies indicated t
213 Pooled analysis of the 7 cross-sectional studies suggest
214 The objective of this study was to conduct a
pooled analysis of the associations of the concentration
215 We did a
pooled analysis of the combined patient populations of t
216 rature by performing a systematic review and
pooled analysis of the data, to understand the extent of
217 risk of incident diabetes (P = 0.001) in the
pooled analysis of the discovery cohort together with th
218 nalysis of summarized published data and the
pooled analysis of the individual original data were sma
219 We performed a
pooled analysis of the interaction between HLA-DRB1 and
220 Pooled analysis of the NHS and WHS cohorts demonstrated
221 Pooled analysis of the paediatric and adult cohorts indi
222 Pooled analysis of the relation between rs33972313 and c
223 This study is a
pooled analysis of the results from the randomised, doub
224 A preplanned
pooled analysis of the results of this study with those
225 A
pooled analysis of the RIBS IV (Restenosis Intra-Stent o
226 This patient-level
pooled analysis of the RIBS IV and RIBS V randomized cli
227 In the
pooled analysis of the studies that included control pat
228 In a
pooled analysis of the three cohorts, psoriatics younger
229 In the
pooled analysis of the three trials, 604 patients were r
230 The
pooled analysis of the two studies demonstrated consiste
231 We report updated results, including a
pooled analysis of the two studies.
232 In a
pooled analysis of the two trials involving the face and
233 In a
pooled analysis of the two trials involving the trunk an
234 Pooled analysis of this study RE-COVER II and the RE-COV
235 In a
pooled analysis of three phase III IPF clinical trials,
236 In this
pooled analysis of two cohorts from the phase 1 dose-exp
237 hial rheoplasty in patients with CB.Methods:
Pooled analysis of two separate studies enrolling 30 pat
238 We performed a
pooled analysis of weight gain in 8 randomized controlle
239 We performed a
pooled analysis of weight gain in 8 randomized controlle
240 We conducted a joint (
pooled) analysis of three genome-wide association studie
241 4200 patients were included in the
pooled analysis,
of whom 1320 received an aromatase inhi
242 ases and 569 controls, P = 7.1e-03) and in a
pooled analysis (
P = 1.8e-04), with an over-representati
243 In a
pooled analysis,
participants with both the Hp2-2 genoty
244 ternational Lymphoma Epidemiology Consortium
pooled analysis,
polymorphisms in 2 immune-system-relate
245 This large
pooled analysis provided sufficient numbers of related f
246 tudies included in the largest international
pooled analysis published to date in order to estimate o
247 present large-scale individual patient-data
pooled analysis,
recent smoking was unrelated to infarct
248 d in each Phase III study, as well as in the
pooled analysis,
regardless of endpoint or analysis popu
249 The findings of this large
pooled analysis reinforce the hypothesis that day-care c
250 Pooled analysis resulted in a crude OR of 1.25 (95% CI:
251 Pooled analysis revealed 18% lower 5-year all-cause mort
252 Pooled analysis revealed baseline demographic factors as
253 Pooled analysis revealed baseline demographic factors as
254 A
pooled analysis revealed that the elimination of daily r
255 Pooled analysis revealed that there was a significant in
256 In the
pooled analysis,
seven additional insertions or deletion
257 Pooled analysis showed a protective effect of ASD closur
258 The
pooled analysis showed an overall significant weight red
259 Pooled analysis showed nonsignificantly lower maternal v
260 At 24 months, our
pooled analysis showed preventive treatment reduced the
261 Pooled analysis showed that in women age >/= 50 years, s
262 Overall, the
pooled analysis showed that mir-196a2 rs11614913 was ass
263 Compared with the lowest category, the
pooled analysis showed that the highest Mediterranean di
264 In the
pooled analysis,
significantly fewer moderate and severe
265 This patient-level
pooled analysis sought to compare outcomes of 3 large, f
266 In
pooled analysis,
statins were not associated with increa
267 The results of this
pooled analysis suggest that the two endometrial cancer
268 observed between NSAID use and EAC risk, our
pooled analysis suggests a possible role for NSAIDs in p
269 This
pooled analysis suggests that bariatric surgery is assoc
270 The evidence from a
pooled analysis suggests that statins improve survival i
271 The outcomes of this
pooled analysis support minimal volume standards in rect
272 For each end point, we performed
pooled analysis that compared the effects of UDCA with t
273 In the
pooled analysis,
the aOR was 1.48 (95% CI 1.04-2.10; p =
274 In the
pooled analysis,
the difference in weight change during
275 In the
pooled analysis,
the odds ratio for low-grade glioma ass
276 In the
pooled analysis,
the relative reduction in the risk of d
277 In the
pooled analysis,
there was an overall association (odds
278 We performed a
pooled analysis to evaluate the relationship between NNR
279 We performed a
pooled analysis to investigate these associations.
280 Pooled analysis using a random-effects model demonstrate
281 ation for mass HCC screening, we conducted a
pooled analysis using data from three cohorts involving
282 The trials were analysed separately and a
pooled analysis was also done.
283 Pooled analysis was based on random effects models.
284 A
pooled analysis was conducted of NHS, ICARE, and the 1 p
285 A multicenter
pooled analysis was conducted with the use of individual
286 An individual-level prospective
pooled analysis was conducted.
287 Pooled analysis was done using a random-effects model, a
288 A
pooled analysis was performed and subgroup analysis was
289 A
pooled analysis was performed based on individual partic
290 A
pooled analysis was performed by using patient data and
291 A
pooled analysis was performed to identify factors associ
292 An individual, patient-level,
pooled analysis was performed using data from five clini
293 all identified studies were included, a new
pooled analysis was performed.
294 A patient-level
pooled analysis was undertaken in 3 federally-funded tri
295 Using a collaborative
pooled analysis,
we examined whether early mortality aft
296 For this
pooled analysis,
we searched all available studies and i
297 In this retrospective
pooled analysis,
we used the M-SKIP Project, the Italian
298 als (TRAFFIC and TRANSPORT) included in this
pooled analysis were multinational, randomised, double-b
299 Primary and secondary end points of
pooled analysis were overall survival and disease-free s
300 This
pooled analysis with a follow-up of more than 10 years c